Literature DB >> 10373236

Update on the systolic hypertension in Europe (Syst-Eur) trial. The Syst-Eur Investigators.

J A Staessen1, L Thijs, W H Birkenhäger, C J Bulpitt, R Fagard.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10373236     DOI： 10.1161/01.hyp.33.6.1476

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  9 in total

1.  Unmet needs in hypertension: challenges and opportunities.

Authors:  J D Jackson; P Merat
Journal:  Curr Hypertens Rep       Date:  1999-12       Impact factor: 5.369

Review 2.  Isolated systolic hypertension and the risk of vascular disease.

Authors:  Tim Nawrot; Elly Den Hond; Lutgarde Thijs; Jan A Staessen
Journal:  Curr Hypertens Rep       Date:  2003-10       Impact factor: 5.369

3.  Methods underpinning national clinical guidelines for hypertension: describing the evidence shortfall.

Authors:  Fiona Campbell; Heather O Dickinson; Julia V F Cook; Fiona R Beyer; Martin Eccles; James M Mason
Journal:  BMC Health Serv Res       Date:  2006-04-05       Impact factor: 2.655

4.  How well can blood pressure be controlled? Progress report on the Systolic Hypertension in Europe Follow-Up Study (Syst-Eur 2).

Authors:  Lutgarde Thijs; Jan A Staessen; Sonia Beleva; Willem H Birkenhäger; Christopher J Bulpitt; Hilde Celis; Astrid E Fletcher; Rumjana Kermova; Gastone Leonetti; Tovio Laks; Stefan Mantov; Choudomir Nachev; Cinzia Sarti; Jaakko Tuomilehto; Robert H Fagard
Journal:  Curr Control Trials Cardiovasc Med       Date:  2001-10-18

5.  The Effects of Eplerenone on the Circadian Blood Pressure Pattern and Left Ventricular Hypertrophy in Patients with Obstructive Sleep Apnea and Resistant Hypertension-A Randomized, Controlled Trial.

Authors:  Beata Krasińska; Szczepan Cofta; Ludwina Szczepaniak-Chicheł; Piotr Rzymski; Tomasz Trafas; Lech Paluszkiewicz; Andrzej Tykarski; Zbigniew Krasiński
Journal:  J Clin Med       Date:  2019-10-13       Impact factor: 4.241

6.  Effect of a nurse-led lifestyle choice and coaching intervention on systolic blood pressure among type 2 diabetic patients with a high atherosclerotic cardiovascular risk: study protocol for a cluster-randomized trial.

Authors:  William Lumu; Davis Kibirige; Ronald Wesonga; Silver Bahendeka
Journal:  Trials       Date:  2021-02-11       Impact factor: 2.279

7.  Randomised double-blind comparison of placebo and active drugs for effects on risks associated with blood pressure variability in the Systolic Hypertension in Europe trial.

Authors:  Azusa Hara; Lutgarde Thijs; Kei Asayama; Lotte Jacobs; Ji-Guang Wang; Jan A Staessen
Journal:  PLoS One       Date:  2014-08-04       Impact factor: 3.240

8.  The impact of acetylsalicylic acid dosed at bedtime on circadian rhythms of blood pressure in the high-risk group of cardiovascular patients-a randomized, controlled trial.

Authors:  Beata Krasińska; Lech Paluszkiewicz; Ewa Miciak-Ławicka; Maciej Krasinski; Piotr Rzymski; Andrzej Tykarski; Zbigniew Krasiński
Journal:  Eur J Clin Pharmacol       Date:  2020-09-21       Impact factor: 2.953

9.  Benefits of antihypertensive pharmacologic therapy and blood pressure reduction in outcome trials.

Authors:  Ji-Guang Wang; Jan A Staessen
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jan-Feb       Impact factor: 3.738
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.